AFIB OTC
Acutus Medical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: -88.9%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$20M
+181.4% ▲
5Y CAGR: +48.0%
Gross Profit
$1M
+132.3% ▲
Operating Income
-$57K
+99.6% ▲
Net Income
-$10M
+88.3% ▲
EPS (Diluted)
$-0.32
+88.6% ▲
EBITDA
$2M
+142.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $8M | $17M | $3M | $7M | $20M |
| YoY Growth | +198.4% | +104.0% | -82.4% | +136.4% | +181.4% |
| Cost of Revenue | $16M | $33M | $32M | $10M | $19M |
| Gross Profit | -$7M | -$16M | -$2M | -$3M | $1M |
| Gross Margin | -87.7% | -90.7% | -63.0% | -43.8% | 5.0% |
| R&D Expenses | $33M | $37M | $28M | $3M | $0 |
| SG&A Expenses | $50M | $64M | $48M | $8M | $10M |
| Operating Expenses | $84M | $96M | $21M | $11M | $1M |
| Operating Income | -$91M | -$116M | -$23M | -$14M | -$57K |
| Operating Margin | -1079.1% | -671.2% | -757.9% | -200.5% | -0.3% |
| Interest Expense | $6M | $6M | $5M | $6M | $6M |
| Income Before Tax | -$102M | -$118M | $29M | -$12M | -$5M |
| Tax Expense | $23K | $0 | $15K | $63K | $0 |
| Net Income | -$102M | -$118M | -$40M | -$82M | -$10M |
| Net Margin | -1204.9% | -681.7% | -1307.0% | -1139.9% | -47.4% |
| EPS (Diluted) | $-8.94 | $-4.11 | $-1.39 | $-2.81 | $-0.32 |
| EBITDA | -$93M | -$105M | $35M | -$5M | $2M |
| Shares Outstanding | 11M | 29M | 28M | 29M | 30M |